MM&M Podcast: Life sciences leadership consultant Lynn Lapierre discusses how the route to the top has changed in biopharma, why pharma is shedding jobs now and where the hot jobs will be going forward.
Is Pharma Losing the Centerpiece of Its Market Access Toolbox?
PharmaExec
Patient-partnered drug discovery: vision or reality? Pharmaphorum talks to Anthony Yanni, Astellas, about why partnering with patients is the cornerstone for change.
Here he reveals how, in his new role, he will use this defining principle to reshape the very foundations of the organisation.
Policy Outlook 2020: Expect loads of talk, little action around biggest healthcare issues,
MM&M
Congratulations to our members acknowledged in GreenBook's Market Leaders Report of top MR firms in the U.S.,
download report
|
|
HRW Expands Strategic Leadership Team with Sue Rees
|
“Sue’s skills and talents will be put to great use as HRW moves into the next phase of our strategic growth. I’m thrilled she is joining us and look forward to working with her and the rest of the leadership team to drive HRW onward and upward.”
Christine Dalzell, Global Managing Director
|
|
|
Involvement in a professional community is your key to success!
Leverage the support of your year-round, member-powered community fueled by 100+ volunteers, advised by 24 pharmaceutical, biotech, medical device & diagnostics leaders.
|
|
We share articles daily on the Intellus LinkedIn company page.
Follow us to see share-worthy articles in your feed.
|
|
Stephen Klasko, MD, President/CEO of Thomas Jefferson University & Jefferson Health
Is There an Avatar In the House: Changing the DNA of Healthcare in the Age of AI and Population Health
What we are doing wrong in “protecting the old failed system” & what innovation, digital health, genomics, machine learning & transparency can do to create positive disruption. Predicts the Category 5 disruptions that will have healthcare join the consumer revolution & have population health, predictive analytics & reducing health inequities enter the mainstream of clinical care & payment models.
|
|
Barbara Kahn, Professor of Marketing, Wharton School & Executive Director, Marketing Science Institute
Marketing Strategy: How to Compete in the Age of Disruption
Examine retailing companies most successful during this wave of change & present a framework that any company can use to create a competitive strategy to thrive in today's – and tomorrow's – disruptive environment
|
|
Glenna M. Crooks, PhD, The NetworkSage, Author & Alan Golombek, Complete Renal Care, Inc.
The NetworkSage – Networks that Support the Patient Journey and Outcomes
The next step in the evolution of understanding the customer experience –be they patient, caregiver or health care professional – will come from understanding the entire context of life as they live it as a person. A Metastatic Breast Cancer case study will demonstrate the value of this approach for improving the experience of a patient & caregiver. Co-presenting will be the surviving spouse of the woman whose story we’ll tell. Books sponsored by ThinkGen.
|
|
Affordable Online Education
Access 35+ live and on demand sessions hosted by Intellus community experts and our BHBIA partners. New topics from BHBIA include: Patient Centricity, Physician and Patient Qualitative Research Techniques, Pharmacovigilance in Social Media Research, Implications of Brexit, Modern Survey Design Masterclass, Forecasting & AE in Motion
|
|
|
|
Recognize the accomplishments of those who inspire you!
|
Submissions for the Clement-Fordyce Lifetime Achievement & Impact Awards are due in March and presented during the Summit.
|
|
|
|
Members (and their HR counterparts) post jobs for free on our job board,
click here for details.
Latest postings by InCrowd, Inspire, RomAnalytics & SKIM
|
|
|
EphMRA & Intellus Worldwide's Classification Committee prepares the annual guidelines for this classification system and manages new entries, changes and improvements in consultation with pharmaceutical manufacturers.
Intellus Worldwide maintains a permanent seat on the Committee to ensure US manufacturers are represented in classification decisions.
Intellus Worldwide manufacturer members receive opportunity to vote on all classification proposals (Spring each year). Most (if not all) drug-level, secondary databases follow the EphMRA/Intellus Worldwide classification. The WHO ATC Drug Classification System was adapted from the EphMRA/Intellus Worldwide system, and a meeting is held each year between the two Committees to preserve harmonization (where possible) between the two systems.
|
|
View our
Health Literacy Resources to discover tools and understanding required to address the growing needs of patients with a variety of health literacy levels, and how to equip patients to better understand their treatments, control their own health decisions and improve outcomes.
|
|
2020 Regional Events
August 20 - Chicago Botanic Garden
Late August - San Francisco
Late September - New Jersey
Early October - Boston
More details will be announced soon!
|
|
Intellus Worldwide has partnered with BHBIA to provide both our memberships complimentary access to webinars. BHBIA webinars accessible through the
Virtual Learning Center.
|
|
Intellus Worldwide is the leading organization for healthcare insights and analytics, including global manufacturers and service providers within pharmaceuticals, biotech, medical device and diagnostics.
|
|
Formed in 2018 when two renowned industry associations joined forces, PBIRG (Pharmaceutical Business Intelligence & Research Group) and PMRG (Pharmaceutical Marketing Research Group) bring 50+ years of experience empowering our community through advocacy and professional development.
|
|
|
|
|
|
|
